News: FDA’s Rapid Approval of Esketamine for Severe Depression Questioned   Medscape News Pauline Anderson November 13, 2019 https://www.medscape.com/viewarticle/921248#vp_1 While some experts have hailed intranasal esketamine (Spravato, Janssen) as a “game changer” for treatment-resistant depression (TRD), others are concerned over the US Food and Drug Administration’s (FDA) rapid approval of the drug. In an editorial Read More …